Connect with us

Published

on

Cells that make up the cartilage at the end of children’s and teens’ bones determine their future length and shape, which, in turn, affect height.  (Image credit: Marko Geber via Getty Images)

Scientists have pinpointed 145 potential “height genes” in cells that make up the cartilage at the ends of children’s bones and affect how tall they grow.

These cartilage cells, known as chondrocytes, multiply and mature in areas of tissue called growth plates, which sit near the ends of long bones in children and teens and determine each bone’s future length and shape. When a person’s growth is complete, these cartilaginous growth plates “close” and are replaced by hard bone. Scientists already knew that chondrocytes play a role in bone growth and human height, but narrowing down which genes control the cells’ growth — and, thus, our statures — has proved difficult.

“Pinpointing specific genes associated with human height is a challenging task, as height is a complex trait that is influenced by both genetic and environmental factors,” Dr. Nora Renthal (opens in new tab) , a pediatric endocrinologist at Boston Children’s Hospital and Harvard Medical School and senior of the new study, told Live Science in an email. “Our study focused on cartilage cells specifically because they are the primary cell type involved in bone growth.”

In a study published Friday (April 14) in the journal Cell Genomics (opens in new tab) , Renthal and her colleagues screened 600 million mouse cartilage cells to find genes that influence how the cells proliferate and mature. They used CRISPR genome-editing technology to “knock out” candidate genes, which allowed the researchers to observe what happened when these genes were erased and no longer regulated cartilage cells.

Related: What determines a person’s height? 

The researchers found 145 genes that, when knocked out, triggered abnormal growth and development of mouse cartilage cells. These patterns of abnormal growth were similar to those seen in certain skeletal disorders, such as skeletal dysplasia — a group of genetic disorders that affect the development of bones, joints and cartilage in babies. Those with skeletal dysplasia are typically of short stature and have short limbs, among other symptoms.

Next, the researchers compared these 145 mouse genes with previous results from large-scale genetic studies of human height, called genome-wide association studies (GWAS). In those studies, researchers compared the DNA of thousands of people of different heights to look for gene variants associated with height, Renthal explained. To control for non-genetic factors that influence the trait under study, such as nutrition and disease in the case of human height, these factors are incorporated into GWAS, according to a 2021 review published in the journal Nature Reviews Methods Primers (opens in new tab) .

“These studies have contributed to our understanding of the genetic basis of complex traits like height by identifying specific genetic regions and genes that are associated with the trait,” Renthal said.

The comparison revealed a remarkable overlap between genetic “hotpots” linked to human height in the GWAS and the 145 genes that control cartilage cell growth in mice. This means that these genes, which the researchers have now precisely located in the human genome, could influence height more than other genetic factors do.RELATED STORIES—More than 150 ‘made-from-scratch’ genes are in the human genome. 2 are totally unique to us.

—DeepMind’s AI used to develop tiny ‘syringe’ for injecting gene therapy and tumor-killing drugs

—Humans’ big-brain genes may have come from ‘junk DNA’ 

“Our current study has helped to identify new genes potentially involved in bone growth and development,” Renthal said. “Specific genes and pathways involved in the maturation and proliferation of chondrocytes, the cells that make up cartilage in our bones, play a critical role in human height.”

Results from mouse cells may not mirror cellular processes in humans, Renthal noted in a statement (opens in new tab) , but the researchers think height genes could come in handy in clinical settings. 

“It is our hope that the identification of these 145 genes will help patients with skeletal dysplasia and other skeletal disorders,” Renthal told Live Science.

Continue Reading

Sports

‘Gritty’ McBain secures 5-year deal from Mammoth

Published

on

By

'Gritty' McBain secures 5-year deal from Mammoth

SALT LAKE CITY — The Utah Mammoth re-signed center Jack McBain to a five-year contract worth $21.25 million on Monday.

McBain will count $4.25 million against the salary cap through the 2029-30 NHL season, which was announced a little more than 24 hours since the team elected salary arbitration with the restricted free agent forward.

“He is a big, strong, physical player who competes hard on a nightly basis and brings a gritty toughness to our group,” general manager Bill Armstrong said. “Jack is an important part of the championship-caliber team we are building, and we look forward to having him back on our roster for the foreseeable future.”

McBain, 25, is coming off setting a career high with 27 points and playing all 82 games. He was one of six players to skate in every game of the organization’s first season in Salt Lake City.

“Jack’s versatility as a player, his care for his teammates and his demonstrated willingness to do whatever it takes to win, are all critical elements to our future team success,” president of hockey operations Chris Armstrong said.

McBain has 82 points in 241 games with the franchise, which moved to Utah from Arizona. Since debuting in April 2022, he ranks third in the league with 832 hits.

Continue Reading

Sports

Johnson, 2-time Cup winner with Lightning, retires

Published

on

By

Johnson, 2-time Cup winner with Lightning, retires

Tyler Johnson has announced his retirement after playing 13 NHL seasons and winning the Stanley Cup twice with the Tampa Bay Lightning.

Johnson called it a career in a lengthy message posted on social media Monday. Johnson had battled injuries in recent years and is set to turn 35 on July 29.

“As a short kid from a small town, I saw my chances of playing in the NHL as very slim,” Johnson wrote on Instagram. “But my family — my parents, Ken and Debbie, and my grandparents — believed in me when doubt clouded my mind. Their unwavering faith turned that dream into reality.”

Listed at 5-foot-8 and 191 pounds, Johnson won at just about ever level, capturing the Western Hockey League and Memorial Cup championships in 2008 with his hometown Spokane Chiefs and the Calder Cup championship with Norfolk of the American Hockey League in 2012.

The NHL brought more success, as he skated in 863 regular-season and playoff games since debuting in the league in 2013, putting up 498 points. Johnson was part of the Lightning’s core when they reached the final in 2015 and helped them hoist the Cup back to back in 2020 and ’21.

Johnson finished with Chicago, playing three seasons with the Blackhawks, and Boston, signing with the Bruins early last season following his training camp tryout.

“After a lifetime devoted to hockey, I’m ready for what’s next,” Johnson said. “This moment is bittersweet, but I leave the game with no regrets.”

Continue Reading

Sports

‘Workhorse’ York nets five-year deal from Flyers

Published

on

By

'Workhorse' York nets five-year deal from Flyers

Cam York and the Philadelphia Flyers agreed to terms Monday on a five-year contract worth $25.75 million, with re-signing the restricted free agent defenseman completing perhaps the team’s last important piece of offseason business.

York, 25, will count $5.15 million against the salary cap through the 2029-30 NHL season. That price could turn out to be a bargain with the upper limit rising from $88 million this past season to $113.5 million by 2027-28.

“Cam has been a workhorse for our team over the last few seasons,” general manager Danny Briere said. “We’re excited by his development and look forward to his continued growth and emergence as a young leader within our group.”

The Flyers are trying to shift from rebuilding to contending, and York was the final player on the roster without a contract. They acquired Trevor Zegras in a trade from Anaheim last month and signed fellow center Christian Dvorak and backup goaltender Dan Vladar on the first day of free agency.

York, the 14th pick in the 2019 draft, has skated nearly 21 minutes a game so far in his pro career, all with Philadelphia. He has 77 points in 235 games for the Flyers, who have not made the playoffs since 2020.

“I believe in this team, and I love the direction we are heading,” York said. “I couldn’t be more excited to continue this journey and build something special together.”

Continue Reading

Trending